- cafead Jul 16, 2021 at 11:12: AM
via A couple weeks after activist investor Elliott began its long-awaited attack on CEO Emma Walmsley, GlaxoSmithKline has unveiled a plan to sell over a third of the land at its Stevenage, UK, site to create “one of Europe’s largest ‘clusters’ for biotechnology” and early-stage life sciences companies.
article source
article source